Difficulty in identification of patients with active secondary progressive multiple sclerosis by clinical classification tools

Should We Use Clinical Tools to Identify Disease Progression?

(2021) Hernan Inojosa et al.   Frontiers in Neurology

A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation Study

(2020) Tjalf Ziemssen et al.   JOURNAL OF MEDICAL INTERNET RESEARCH

The window of opportunity for treatment of progressive multiple sclerosis

(2020) Per Soelberg Sorensen et al.   CURRENT OPINION IN NEUROLOGY

Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials

(2020) Ludwig Kappos et al.   JAMA Neurology

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

A Proposal for a Patient-Oriented Five-Dimensional Approach for Surveillance and Therapy in Multiple Sclerosis

(2017) Yavor Yalachkov et al.   Frontiers in Neurology

Defining secondary progressive multiple sclerosis

(2016) Johannes Lorscheider et al.   BRAIN

Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis

(2014) Ilana Katz Sand et al.   Multiple Sclerosis Journal

Multiple sclerosis

(2012) Alyssa Nylander et al.   JOURNAL OF CLINICAL INVESTIGATION